Decoding genetic information to improve global health.
MedGenome is a global leader in genomics-based diagnostics and research services, offering over 1,300 genetic tests spanning oncology, rare diseases, prenatal diagnostics, neurology, and infectious diseases. Founded in 2013 and headquartered in Bangalore, India, MedGenome operates across three core business lines: genomic diagnostics for clinical use, genomic research services for pharmaceutical and biotech partners, and drug discovery solutions powered by real-world genomic data. The company provides DNA sequencing, bioinformatics analysis, and multiomics services to healthcare providers, research institutions, and biopharma companies globally. Its US arm was rebranded as Signios Biosciences in 2025, offering sequencing and multiomics services from Foster City, California.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountUnknown
Unknown
Unknown
Unknown
Jul 2025
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
